AMISHA SPILLE: Open Payments
NPI 1437561040 · URBANA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 16 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $348 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Organon LLC | 1 | $23 |
| ORPHALAN INC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: RINVOQ, SKYRIZI, GATTEX, XIFAXAN, CREON, HADLIMA, CUVRIOR, VOWST.
Industry payments across IL — which companies pay providers there.
